HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prospective Randomized Intraindividual Comparison of Posterior Capsule Opacification After Implantation of an IOL With and Without Heparin Surface Modification.

AbstractPURPOSE:
To compare posterior capsule opacification (PCO) of a hydrophobic acrylic heparin surface modified intraocular lens (HSM-IOL) and an uncoated IOL (UC-IOL) 1 year after implantation.
METHODS:
One hundred two eyes of 51 patients underwent routine phacoemulsification with randomized implantation of a HSM-IOL in one eye (the HSM-IOL group) and a UC-IOL in the fellow eye (the UC-IOL group). Morphologic PCO evaluation was performed comparing digital photographs in retroillumination using the Evaluation of Posterior Capsule Opacification (EPCO) system, grading the density of the opacification from 0 to 4 (0 = none, 1 = minimal, 2 = mild, 3 = moderate, and 4 = severe). Distance visual acuities, subjective manifest refraction, pupil size, straylight measurements, flare in the anterior chamber using a laser flare meter, and contrast sensitivity were also evaluated.
RESULTS:
The mean total EPCO score was slightly higher in the HSM-IOL group (0.50 ± 0.45) compared to the UC-IOL group (0.45 ± 0.46), but did not reach statistical significance. No statistically significant differences were found in the other main outcome parameters (straylight measurement, distance visual acuities, flare in the anterior chamber, and mesopic and photopic contrast sensitivity) when comparing both IOLs.
CONCLUSION:
Although the HSM-IOL showed decreased flare 1 day postoperatively, no statistically significant differences regarding PCO were found 1 year postoperatively.
AuthorsEva M Krall, Eva M Arlt, Gerlinde Jell, Clemens Strohmaier, Sarah Moussa, Alois K Dexl
JournalJournal of refractive surgery (Thorofare, N.J. : 1995) (J Refract Surg) Vol. 31 Issue 7 Pg. 466-72 (Jul 2015) ISSN: 1081-597X [Print] United States
PMID26158927 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
CopyrightCopyright 2015, SLACK Incorporated.
Chemical References
  • Coated Materials, Biocompatible
  • Fibrinolytic Agents
  • Heparin
Topics
  • Aged
  • Aged, 80 and over
  • Capsule Opacification (etiology)
  • Coated Materials, Biocompatible (therapeutic use)
  • Contrast Sensitivity (physiology)
  • Female
  • Fibrinolytic Agents (therapeutic use)
  • Heparin (therapeutic use)
  • Humans
  • Lens Implantation, Intraocular (adverse effects)
  • Lenses, Intraocular
  • Light
  • Male
  • Middle Aged
  • Phacoemulsification
  • Posterior Capsule of the Lens (pathology)
  • Prospective Studies
  • Refraction, Ocular (physiology)
  • Scattering, Radiation
  • Visual Acuity (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: